University of California, Irvine

Total Awards: 
34
Approved funds: 
$96,484,462
Major Facility Name: 
Sue and Bill Gross Stem Cell Research Center
Institution type: 
Not for profit

Awards to the Institution

Funding
Early Translational III: Craig Walsh Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells $4,799,814
New Faculty II: Edwin Monuki Mechanisms in Choroid Plexus Epithelial Development $3,169,328
Disease Team Therapy Development - Research: Henry Klassen Retinal progenitor cells for treatment of retinitis pigmentosa $17,306,668
Basic Biology II: Aileen Anderson Role of the microenvironment in human iPS and NSC fate and tumorigenesis $1,284,921
Basic Biology II: Marian Waterman TCF-3: A Wnt Pathway Effector and Nanog Regulator in Pluripotent Stem Cell Self-Renewal $1,277,101
Early Translational I: Frank LaFerla Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease $3,599,997
Early Translational II: Brian Cummings Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury $1,708,549
Early Translational II: Leslie Thompson A hESc-based Development Candidate for Huntington's Disease $3,799,817
Early Translational II: Henry Klassen Human retinal progenitor cells as candidate therapy for retinitis pigmentosa $4,738,251
Early Translational II: leif Havton Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $1,614,441
Comprehensive Grant: Peter Donovan Improved hES Cell Growth and Differentiation $2,509,438
Comprehensive Grant: Douglas Wallace The Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning $2,530,000
Comprehensive Grant: Hans Keirstead hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury $2,396,932
New Faculty I: Andrew Putnam A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells $2,108,683
Training Grant I-1: Peter Bryant Stem Cell Research Training Grant $2,039,845
SEED Grant: Kyoko Yokomori Derivation and characterization of human ES cells from FSHD embryos $632,500
SEED Grant: Thomas Lane Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination $425,594
SEED Grant: Brian Cummings The Immunological Niche: Effect of immunosuppressant drugs on stem cell proliferation, gene expression, and differentiation in a model of spinal cord injury. $619,223
Early Translational IV: Magdalene Seiler Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs) $4,318,439
SEED Grant: Charles Limoli Using human embryonic stem cells to treat radiation-induced stem cell loss: Benefits vs cancer risk $625,617
Basic Biology V: Lisa Flanagan Molecular basis of plasma membrane characteristics reflecting stem cell fate potential $1,003,590
SEED Grant: Frank LaFerla Development of human ES cell lines as a model system for Alzheimer disease drug discovery $492,750
Basic Biology V: Peter Donovan Non-invasive live imaging of stem cell signature metabolic states $540,480
SEED Grant: Vincent Procaccio Mitochondrial Dysfunction in Embryonic Stem Cells $632,500
Major Facilities: Michael Drake No Title $27,156,000
Disease Team Planning: Henry Klassen Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa $37,367
Disease Team Planning: Leslie Thompson Huntington's Disease Team $54,618
Shared Labs: Peter Donovan Regional Human Embryonic Stem Cell Shared Research Laboratory and Stem Cell Techniques Course $5,414,579
Tools and Technologies I: Lisa Flanagan Novel Separation of Stem Cell Subpopulations $871,627
Tools and Technologies I: Orhan NALCIOGLU A Multimodality Molecular Imaging Systen (MRSPECT) for in Vivo Stem Cell Tracking $719,798
New Cell Lines: Leslie Thompson New Cell Lines for Huntington's Disease $1,369,800
SEED Grant: Grant MacGregor Production of Oocytes from Human ES Cells $623,781
Research Training II: Peter Donovan Research Training Program II $6,827,148
SEED Grant: Michelle Khine Micro Platform for Controlled Cardiac Myocyte Differentiation $363,707
Total:
$107,612,903.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine